APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy
…, PL Kimmel, S Limou, TS Ahuja, JS Berns… - Journal of the …, 2011 - journals.lww.com
Trypanolytic variants in APOL1, which encodes apolipoprotein L1, associate with kidney
disease in African Americans, but whether APOL1-associated glomerular disease has a distinct …
disease in African Americans, but whether APOL1-associated glomerular disease has a distinct …
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
…, LM McKenzie, H Kajiyama, TS Ahuja, JS Berns… - Nature …, 2008 - nature.com
The increased burden of chronic kidney and end-stage kidney diseases (ESKD) in
populations of African ancestry has been largely unexplained. To identify genetic variants …
populations of African ancestry has been largely unexplained. To identify genetic variants …
The renal manifestations of thyroid disease
LH Mariani, JS Berns - Journal of the American Society of …, 2012 - journals.lww.com
Thyroid hormones influence renal development, kidney structure, renal hemodynamics, GFR,
the function of many transport systems along the nephron, and sodium and water …
the function of many transport systems along the nephron, and sodium and water …
[HTML][HTML] Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin
S Fishbane, JS Berns - Kidney international, 2005 - Elsevier
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
Background Treatment with recombinant human erythropoietin (rHuEPO) has been a major …
Background Treatment with recombinant human erythropoietin (rHuEPO) has been a major …
KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD–mineral and bone disorder (CKD-MBD)
K Uhlig, JS Berns, B Kestenbaum, R Kumar… - American Journal of …, 2010 - Elsevier
This commentary provides a US perspective on the 2009 KDIGO (Kidney Disease: Improving
Global Outcomes) Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, …
Global Outcomes) Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, …
Reviews: use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease
RW Snyder, JS Berns - Seminars in dialysis, 2004 - Wiley Online Library
Diabetes mellitus is recognized as a leading cause of chronic kidney disease (CKD) and
end‐stage renal disease (ESRD) in the United States. There is a vast array of medications used …
end‐stage renal disease (ESRD) in the United States. There is a vast array of medications used …
Definition and classification of CKD: the debate should be about patient prognosis—a position statement from KDOQI and KDIGO
KU Eckardt, JS Berns, MV Rocco, BL Kasiske - American journal of kidney …, 2009 - ajkd.org
(KDOQI) published a guideline on chronic kidney disease (CKD) covering evaluation,
classification, and stratification of risk. 1 The workgroup developing this guideline provided a new …
classification, and stratification of risk. 1 The workgroup developing this guideline provided a new …
The native kidney biopsy: update and evidence for best practice
JJ Hogan, M Mocanu, JS Berns - Clinical Journal of the American …, 2016 - journals.lww.com
The kidney biopsy is the gold standard in the diagnosis and management of many diseases.
Since its introduction in the 1950s, advancements have been made in biopsy technique to …
Since its introduction in the 1950s, advancements have been made in biopsy technique to …
[HTML][HTML] Nephrotoxic risks of renal angiography: contrast mediaassociated nephrotoxicity and atheroembolism—a critical review
…, JS Berns, RM Cohen, S Goldfarb - American journal of kidney …, 1994 - Elsevier
Renal angiography remains the “gold standard” procedure for the detection of renal artery
stenosis. However, clinicians often avoid renal angiography because of fears of contrast media…
stenosis. However, clinicians often avoid renal angiography because of fears of contrast media…
Tumor lysis syndrome: new challenges and recent advances
FP Wilson, JS Berns - Advances in chronic kidney disease, 2014 - Elsevier
Tumor lysis syndrome (TLS) is an oncologic emergency triggered by the rapid release of
intracellular material from lysing malignant cells. Most common in rapidly growing hematologic …
intracellular material from lysing malignant cells. Most common in rapidly growing hematologic …